Medicure Inc

Research Medicure Inc (MPH) on Bullrun: market cap CAD 13.36M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMPH
• ExchangeV
• CountryCanada
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyCAD
• Market capCAD 13.36M
• Financial periodQ4 2025
• RevenueCAD 8.54M
• Net income-CAD 4.22M
• Free cash flowCAD 32.00K
• Gross margin31.6%

Valuation Snapshot

latest market cap is CAD 13.36M.

About Medicure Inc

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency;

Frequently asked questions

What is Medicure Inc's market cap?

Medicure Inc's market capitalization is CAD 13.36M.

What does Medicure Inc do?

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.